comparemela.com

Page 2 - George Apostol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Greenlights Phase 3 Trials of Quilience for Narcolepsy

NLS Pharmaceutics received FDA authorization to proceed with the phase 3 AMAZE program for Quilience (mazindol ER) for narcolepsy treatment. 

NLS Pharmaceutics Receives Green Light from the U S FDA to Proceed with Phase 3 Clinical Program (AMAZE) for Quilience(R) (Mazindol ER) for the Treatment of Narcolepsy

NLS Pharmaceutics Receives Green Light from the U S FDA to Proceed with Phase 3 Clinical Program (AMAZE) for Quilience(R) (Mazindol ER) for the Treatment of Narcolepsy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

NLS Pharmaceutics AG: NLS Pharmaceutics Receives Green Light from the U S FDA to Proceed with Phase 3 Clinical Program for Quilience for the Treatment of Narcolepsy

ZURICH, SWITZERLAND / ACCESSWIRE / May 2, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development

NLS Pharmaceutics (NLSP) Cleared by FDA to Proceed with Phase 3 Clinical Program for Quilience

NLS Pharmaceutics (NLSP) Cleared by FDA to Proceed with Phase 3 Clinical Program for Quilience
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

NLS Pharmaceutics (NLSP) Presents Latest Preclinical Pipeline Data

NLS Pharmaceutics (NLSP) Presents Latest Preclinical Pipeline Data
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.